These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 24677271

  • 1. Induction of atherosclerosis in mice and hamsters without germline genetic engineering.
    Bjørklund MM, Hollensen AK, Hagensen MK, Dagnaes-Hansen F, Christoffersen C, Mikkelsen JG, Bentzon JF.
    Circ Res; 2014 May 23; 114(11):1684-9. PubMed ID: 24677271
    [Abstract] [Full Text] [Related]

  • 2. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
    Roche-Molina M, Sanz-Rosa D, Cruz FM, García-Prieto J, López S, Abia R, Muriana FJ, Fuster V, Ibáñez B, Bernal JA.
    Arterioscler Thromb Vasc Biol; 2015 Jan 23; 35(1):50-9. PubMed ID: 25341796
    [Abstract] [Full Text] [Related]

  • 3. Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice.
    Denis M, Marcinkiewicz J, Zaid A, Gauthier D, Poirier S, Lazure C, Seidah NG, Prat A.
    Circulation; 2012 Feb 21; 125(7):894-901. PubMed ID: 22261195
    [Abstract] [Full Text] [Related]

  • 4. Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.
    Lu H, Howatt DA, Balakrishnan A, Graham MJ, Mullick AE, Daugherty A.
    Arterioscler Thromb Vasc Biol; 2016 Sep 21; 36(9):1753-7. PubMed ID: 27470509
    [Abstract] [Full Text] [Related]

  • 5. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant.
    Al-Mashhadi RH, Sørensen CB, Kragh PM, Christoffersen C, Mortensen MB, Tolbod LP, Thim T, Du Y, Li J, Liu Y, Moldt B, Schmidt M, Vajta G, Larsen T, Purup S, Bolund L, Nielsen LB, Callesen H, Falk E, Mikkelsen JG, Bentzon JF.
    Sci Transl Med; 2013 Jan 02; 5(166):166ra1. PubMed ID: 23283366
    [Abstract] [Full Text] [Related]

  • 6. Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.
    Jarrett KE, Lee C, De Giorgi M, Hurley A, Gillard BK, Doerfler AM, Li A, Pownall HJ, Bao G, Lagor WR.
    Arterioscler Thromb Vasc Biol; 2018 Sep 02; 38(9):1997-2006. PubMed ID: 30026278
    [Abstract] [Full Text] [Related]

  • 7. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
    Cansby E, Magnusson E, Nuñez-Durán E, Amrutkar M, Pedrelli M, Parini P, Hoffmann J, Ståhlman M, Howell BW, Marschall HU, Borén J, Mahlapuu M.
    Arterioscler Thromb Vasc Biol; 2018 Aug 02; 38(8):1723-1737. PubMed ID: 29930001
    [Abstract] [Full Text] [Related]

  • 8. Targeting proprotein convertase subtilisin/kexin type 9 in mice and monkeys.
    Wang Y, Ma M, Wang JA, Daugherty A, Lu HS.
    Curr Opin Lipidol; 2019 Apr 02; 30(2):154-155. PubMed ID: 30844857
    [No Abstract] [Full Text] [Related]

  • 9. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D, Pöss J, Böhm M, Laufs U.
    J Am Coll Cardiol; 2013 Oct 15; 62(16):1401-8. PubMed ID: 23973703
    [Abstract] [Full Text] [Related]

  • 10. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M, Terao Y, Ayaori M, Uto-Kondo H, Iizuka M, Yogo M, Hagisawa K, Takiguchi S, Yakushiji E, Nakaya K, Ogura M, Komatsu T, Ikewaki K.
    Arterioscler Thromb Vasc Biol; 2014 Jun 15; 34(6):1171-8. PubMed ID: 24675665
    [Abstract] [Full Text] [Related]

  • 11. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.
    Xu L, Dai Perrard X, Perrard JL, Yang D, Xiao X, Teng BB, Simon SI, Ballantyne CM, Wu H.
    Arterioscler Thromb Vasc Biol; 2015 Aug 15; 35(8):1787-97. PubMed ID: 26112011
    [Abstract] [Full Text] [Related]

  • 12. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.
    Maxwell KN, Breslow JL.
    Proc Natl Acad Sci U S A; 2004 May 04; 101(18):7100-5. PubMed ID: 15118091
    [Abstract] [Full Text] [Related]

  • 13. Atherosclerosis Induced by Adeno-Associated Virus Encoding Gain-of-Function PCSK9.
    Bjørklund MM, Bernal JA, Bentzon JF.
    Methods Mol Biol; 2022 May 04; 2419():461-473. PubMed ID: 35237981
    [Abstract] [Full Text] [Related]

  • 14. Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.
    Vozenilek AE, Vetkoetter M, Green JM, Shen X, Traylor JG, Klein RL, Orr AW, Woolard MD, Krzywanski DM.
    J Vasc Res; 2018 May 04; 55(2):98-110. PubMed ID: 29455203
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.
    Cameron J, Bogsrud MP, Tveten K, Strøm TB, Holven K, Berge KE, Leren TP.
    Transl Res; 2012 Aug 04; 160(2):125-30. PubMed ID: 22683370
    [Abstract] [Full Text] [Related]

  • 16. Understanding PCSK9 and anti-PCSK9 therapies.
    McKenney JM.
    J Clin Lipidol; 2015 Aug 04; 9(2):170-86. PubMed ID: 25911073
    [Abstract] [Full Text] [Related]

  • 17. Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor.
    Lambert G, Jarnoux AL, Pineau T, Pape O, Chetiveaux M, Laboisse C, Krempf M, Costet P.
    Endocrinology; 2006 Oct 04; 147(10):4985-95. PubMed ID: 16794006
    [Abstract] [Full Text] [Related]

  • 18. Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo.
    Schmidt RJ, Beyer TP, Bensch WR, Qian YW, Lin A, Kowala M, Alborn WE, Konrad RJ, Cao G.
    Biochem Biophys Res Commun; 2008 Jun 13; 370(4):634-40. PubMed ID: 18406350
    [Abstract] [Full Text] [Related]

  • 19. Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue.
    Roubtsova A, Munkonda MN, Awan Z, Marcinkiewicz J, Chamberland A, Lazure C, Cianflone K, Seidah NG, Prat A.
    Arterioscler Thromb Vasc Biol; 2011 Apr 13; 31(4):785-91. PubMed ID: 21273557
    [Abstract] [Full Text] [Related]

  • 20. A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family.
    Lin J, Wang LY, Liu S, Wang XM, Yong Q, Yang Y, DU LP, Pan XD, Wang X, Jiang ZS.
    Chin Med J (Engl); 2010 May 05; 123(9):1133-8. PubMed ID: 20529551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.